Imatinib Mesylate — A New Oral Targeted Therapy
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases
Imatinib Mesylate and Gray Hair
Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases
Adverse Events after Imatinib Mesylate Therapy
Imatinib Mesylate
